Table 1.
Pt. no. | Age (years)/gender | Primary site | Size (cm) | Prior treatment | Treatment | Recurrence | Metastases | Follow-Up (mo) | Outcome |
---|---|---|---|---|---|---|---|---|---|
Cases of myoepithelioma | |||||||||
1 | 21/M | Parotid | 2.5 × 1.5 | Chemotherapy for T cell lymphoblatic leukemia | Superfical parotidectomy | No | No | 44 | NED |
2 | 44/M | Buccal cortex of mandible | 5 × 4 | Nil | Excision of lesion | No | No | 54 | NED |
3 | 60/M | Parotid | 2.5 × 1.5 | Nil | Superficial parotidectomy | No | No | 4 | NED |
4 | 21/F | Parotid | 1 × 1 | Nil | Superficial parotidectomy | NA | NA | NA | LOF |
5 | 56/F | Soft palate | 2 × 1 | Nil | Excision soft palate mass | NA | NA | NA | LOF |
6 | 30/M | Parotid | 6 × 4 | Nil | Superficial parotidectomy | No | No | 54 | NED |
Cases of Myoepithelial carcinoma | |||||||||
7 | 74/M | Base of tongue | 2 × 2 | Nil | Wide local excision + Radiotherapy | No | No | 45 | NED |
8 | 56/M | Maxilla | 1 × 0.6 | Nil | Partial maxillectomy | No | No | 19 | NED |
9 | 43/F | Parotid | 6 × 5 | Parotid surgery- done elswhere | Total conservative parotidectomy + Endoscopic excision biopsy of nasal mass | Yes | Nasal cavity and brain metastastasis | 8 | DOD |
10 | 55/M | Parotid | 8 × 7 | Total conservative parotidectomy | Radical parotidectomy + Radiotherapy | Yes | No | 1 | Under follow-up |
11 | 83/M | Parotid | 10 × 8 | Parotid surgery- done elswhere | Radical parotidectomy | Yes | No | NA | LOF |
12 | 41/F | Nasopharynx | 3 × 2 | Nil | Endoscopic assisted biopsy + Concurrent Chemoradiation | No | No | 30 | NED |
13 | 33/F | Trachea | 3 × 2.5 | Tumor debulking done | Endobronchial debulking | Yes | No | 40 | DOD |
14 | 32/F | Hard palate | 6 × 4 | Excision of mass + Chemoradiotherapy done elswhere | Chemotherapy | NA | NA | NA | LOF |
15 | 51/M | Bronchus | 2 × 1 | Endobronchial debulking done elswhere | Underwent bronchoscopy | NA | NA | NA | LOF |
cm, centimeter; DOD, died of disease; F, female; LOF, lost to followup; M, male; mo, months; NA, not available; NED, no evidence of disease